Applied DNA Customer ÚHKT Initiates Phase I Clinical Trial for Rapidly Manufacturable CAR T-cell Therapy Produced from LineaDNA
December 18th, 2024
Tag: LinearDNA
APDN Ships First saRNA (self-amplifying mRNA) IVT Template Generated by Linea™ DNA Platform
November 9th, 2023
APDN Partners with Cornell University College of Veterinary Medicine to Accelerate Development of Veterinary Vaccine Platform Targeting Diseases that Impact High-Value Animals
September 14th, 2023
APDN Appoints Beverly Wolgast as Executive Director of Quality and cGMP Programs
September 6th, 2023
Applied DNA Announces Availability and First Customer Shipment of New Linea™ IVT Evaluation Kit
August 29th, 2023
APDN to Establish N. America’s 1st Enzymatic Large-Scale cGMP DNA Manufacturing Capacity in NY
October 24th, 2022
APDN Receives Largest Single Purchase Order for LinearDNA To Date
October 10th, 2022
Manuscript Demonstrates that LinearDNA™ Vaccine Candidate was Protective in Virus Challenge Trial
September 30th, 2022
APDN, Cornell University College of Veterinary Medicine Research Collaboration
September 8th, 2022